Data / Form D filings / Electra Therapeutics, Inc.
Electra Therapeutics, Inc.: Form D filing
Electra Therapeutics, Inc., a biotechnology company in South San Francisco, CA, filed a Form D with the SEC in 2025. The latest, on October 30, 2025, reports $134.2 million sold of a $184.1 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 230 EAST GRAND AVENUE, SUITE S-100, South San Francisco, CA, 94080
- Phone
- (888) 743-2290
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2088082
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 30, 2025 | New notice | $184,133,425 | $134,188,389 | $49,945,036 | 19 | Oct 15, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Beth Seidenberg, M.D. | Director | |
| Thomas Geninatti, Ph.D. | Director | |
| Matthew Fust | Director | |
| Carl Gordon, Ph.D. | Director | |
| Nancy Stagliano, Ph.D. | Director | |
| Quehuong (Kathy) Dong, Pharm.D. | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Oct 27, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Electra Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.